Lung cancer is the predominant cause of cancer-related deaths. The high mortality rates are mainly due to the lack of diagnosis before the cancer is at a late stage. Liquid biopsy is a promising technique...
Read More »Bio-Techne’s new exosome-based liquid biopsies helping to advance personalized care in lung cancer diagnostics
Bio-Techne have researchers published a validation study demonstrating that the proprietary exosome-based liquid biopsy tests from Bio-Techne’s Exosome Diagnostics brand may be used to assess the...
Read More »Aspirin inhibits hypoxia-mediated lung cancer cell stemness and exosome function
Epidemiological studies have illustrated that regular aspirin consumption may decrease the risk of non-small cell lung cancer (NSCLC). Zhujiang Hospital researchers investigated the mechanism of aspirin-induced inhibition of NSCLC development during hypoxia. A549 cells were pre-treated with the vehicle control ...
Read More »Direct isolation and characterization of circulating exosomes from biological samples using magnetic nanowires
Tumor-derived exosomes are gaining attention as important factors that facilitate communication between neighboring cells and manipulate cellular processes associated with cancer development or...
Read More »New exosome research clarifies the relation between pneumoconiosis and lung cancer
Exposure to nanoparticles may lead to pneumoconiosis and lung cancer; however, whether patients suffering from pneumoconiosis also face a...
Read More »Exosomes as theranostics for lung cancer
Extensive research in genetics and genomics has revealed that lung cancer is a physiologically complex and genetically heterogeneous disease. Although molecular targets that can yield favorable response...
Read More »Liquid biopsy for lung cancer early detection
Molecularly targeted therapies and immune checkpoint inhibitors have markedly improved the therapeutic management of advanced lung cancer. However, it still remains the leading cause of cancer-related mortality worldwide, with disease stage at diagnosis representing the main prognostic factor. Detection of ...
Read More »Lung Cancer Liquid Biopsy Market Size Estimated to Observe Significant Growth
Liquid biopsy is a non-invasive substitute to surgical biopsies for the detection of molecular biomarkers. Liquid biopsy forms an integral part of precision...
Read More »Clinical validation of liquid biopsy for the differential diagnosis of early stage lung cancer
Integrated Diagnostics today announced the e-publication of full results of a large prospective clinical trial validating its Xpresys Lung 2® in the peer-reviewed medical journal CHEST, the official journal of the American College of Chest Physicians, titled: Assessment of Plasma Proteomics ...
Read More »Blood-based tumor biomarkers in lung cancer for detection and treatment
The therapeutic landscape of lung cancer has expanded significantly over the past decade. Advancements in molecularly targeted therapies, strategies to discover and treat resistance mutations, and development of personalized cancer treatments in the context of tumor heterogeneity and dynamic tumor ...
Read More »